Cocrystal Enables Fixed-Dose Empagliflozin and Metformin Bilayer for Bioequivalence
A new approach to diabetes treatment has moved from the bench to the bedside: researchers report a cocrystal-enabled, bilayer fixed-dose tablet combining empagliflozin and metformin,...















